Rossari Biotech posts Q1 FY25 consolidated PAT at Rs. 34.89 Cr

Rossari Biotech posts Q1 FY25 consolidated PAT at Rs. 34.89 Cr

By: ICN Bureau

Last updated : July 21, 2024 8:26 pm



Rossari Biotech has reported total income of Rs. 490.59 crores during the period ended June 30, 2024


Rossari Biotech Limited has reported consolidated financial results for the period ended June 30, 2024.

Rossari Biotech has posted net profit of Rs. 34.89 crores for the period ended June 30, 2024 as against net profit of Rs. 34.13 crores for the period ended March 31, 2024. The company posted net profit of Rs. 29.21 crores for the period ended June 30, 2023.

Rossari Biotech has reported total income of Rs. 490.59 crores during the period ended June 30, 2024 as compared to Rs. 473.10 crores during the period ended March 31, 2024. The company reported total income of Rs. 412.79 crores during the period ended June 30, 2023.

Rossari Biotech Limited

First Published : July 21, 2024 12:00 am